These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 18505963)
1. Vitamin D and prostate cancer risk--a less sunny outlook? Mucci LA; Spiegelman D J Natl Cancer Inst; 2008 Jun; 100(11):759-61. PubMed ID: 18505963 [No Abstract] [Full Text] [Related]
2. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important? Barry MJ; Mulley AJ J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451 [No Abstract] [Full Text] [Related]
4. Is screening for prostate cancer the current gold standard?--"no". Kramer BS; Gohagan JK; Prorok PC Eur J Cancer; 1997 Mar; 33(3):348-53. PubMed ID: 9155515 [No Abstract] [Full Text] [Related]
5. Screening for prostate cancer - will we ever know? Adolfsson J Acta Oncol; 2010 Apr; 49(3):275-7. PubMed ID: 20397764 [No Abstract] [Full Text] [Related]
6. Screening for prostate cancer: the role of prostate-specific antigen. Ferrer RL Md Med J; 1996 Nov; 45(11):938-40. PubMed ID: 8942171 [No Abstract] [Full Text] [Related]
8. Prostate cancer elder alert. Epidemiology, screening, and early detection. Bruner DW; Pickett M; Joseph A; Burggraf V J Gerontol Nurs; 2000 Jan; 26(1):6-15; quiz 54-5. PubMed ID: 10776164 [No Abstract] [Full Text] [Related]
9. PSA screening and prostate cancer incidence. Berman JJ; Moore GW; Alonsozana EL; Brown LA JAMA; 1996 Apr; 275(15):1155-6. PubMed ID: 8609674 [No Abstract] [Full Text] [Related]
10. Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median. Loeb S; Nadler RB; Roehl KA; Antenor JA; Catalona WJ J Urol; 2007 May; 177(5):1745-8. PubMed ID: 17437803 [TBL] [Abstract][Full Text] [Related]
11. Celebrating the death of PSA screening? Gomella LG Can J Urol; 2011 Dec; 18(6):5987. PubMed ID: 22166323 [No Abstract] [Full Text] [Related]
12. Screening for prostate cancer. Brawley OW; Ankerst DP; Thompson IM CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245 [TBL] [Abstract][Full Text] [Related]
14. Prostate Cancer Screening and the Associated Controversy. Tabayoyong W; Abouassaly R Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521 [TBL] [Abstract][Full Text] [Related]
15. PSA screening and prostate cancer incidence. Rhoads GG; Mills OF JAMA; 1996 Apr; 275(15):1155-6. PubMed ID: 8609675 [No Abstract] [Full Text] [Related]
16. Screening for adenocarcinoma of the prostate. Elias PH Mayo Clin Proc; 2006 Jan; 81(1):132; author reply 132-3. PubMed ID: 16438491 [No Abstract] [Full Text] [Related]
17. What is the value of screening for prostate cancer in the US? Albertsen PC Nat Clin Pract Oncol; 2005 Nov; 2(11):536-7. PubMed ID: 16270077 [No Abstract] [Full Text] [Related]